GlaxoSmithKline is to sell off its famous bedtime malted milk drink Horlicks in the UK, and will also consider exiting a pharma business, its cephalosporins antibiotics franchise. This gloomy news ...

GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...

In an exchange notification, HUL said that the notice was issued over the non-deduction of tax deducted at source (TDS) for ...

Hindustan Unilever had acquired GlaxoSmithKline’s health-food-drinks (HFD) portfolio, which includes the Horlicks brand, in ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

In Dec 2018, HUL announced the merger of GSK Consumer Healthcare with the company. Under the terms of the merger deal, which was completed in 2020, HUL acquired the Horlicks brand for India from ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all ...

GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline GSK could beat Pfizer to market, says chief commercial officer Several drugmakers are betting on mRNA seasonal flu vaccines ...

On July 31, GSK released its financial results for the second quarter of 2024, which again beat analysts' expectations by a wide margin. Under Emma Walmsley's leadership, the company is becoming a ...

GSK (NYSE:GSK) stock was up 3% in afternoon trading Tuesday in the wake of a ruling by a Delaware court on whether certain evidence should be allowed in an ongoing case over the safety of its ...

The acquisition of the GSK business was completed in 2020 ... for the acquisition which included Horlicks, Boost, Maltova, and Viva. “The company has a strong case on merits on tax not withheld ...